Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?

An area that has come to be of tremendous interest in tumor research in the last decade is the role of the microenvironment in the biology of neoplastic diseases. The tumor microenvironment (TME) comprises various cells that are collectively important for normal tissue homeostasis as well as tumor progression or regression. Seminal studies have demonstrated the role of the dialogue between cancer cells (at many sites) and the cellular component of the microenvironment in tumor progression, metastasis, and resistance to treatment. Using an appropriate system of microenvironment and tumor culture is the first step towards a better understanding of the complex interaction between cancer cells and their surroundings. Three-dimensional (3D) models have been widely described recently. However, while it is claimed that they can bridge the gap between in vitro and in vivo, it is sometimes hard to decipher their advantage or limitation compared to classical two-dimensional (2D) cultures, especially given the broad number of techniques used. We present here a comprehensive review of the different 3D methods developed recently, and, secondly, we discuss the pros and cons of 3D culture compared to 2D when studying interactions between cancer cells and their microenvironment.

[1]  Ronald T Raines,et al.  Collagen structure and stability. , 2009, Annual review of biochemistry.

[2]  Martin Fussenegger,et al.  Design of artificial myocardial microtissues. , 2004, Tissue engineering.

[3]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[4]  D. Landis,et al.  Microfluidic Biopsy Trapping Device for the Real-Time Monitoring of Tumor Microenvironment , 2017, PloS one.

[5]  Albert Jin,et al.  Local 3D matrix microenvironment regulates cell migration through spatiotemporal dynamics of contractility-dependent adhesions , 2015, Nature Communications.

[6]  M. Bissell,et al.  Cytodifferentiation of mouse mammary epithelial cells cultured on a reconstituted basement membrane reveals striking similarities to development in vivo. , 1991, Journal of cell science.

[7]  Kristi S Anseth,et al.  PEG-peptide hydrogels reveal differential effects of matrix microenvironmental cues on melanoma drug sensitivity. , 2017, Integrative biology : quantitative biosciences from nano to macro.

[8]  Arash Rafii,et al.  Epithelial to Mesenchymal Transition in a Clinical Perspective , 2015, Journal of oncology.

[9]  M J Bissell,et al.  Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. , 1989, Development.

[10]  J. McGee,et al.  Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids , 2015, Oncotarget.

[11]  D. Fennell,et al.  Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. , 2009, American journal of respiratory cell and molecular biology.

[12]  R. Bast,et al.  Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer , 2010, Molecular Cancer Therapeutics.

[13]  D. Wolf,et al.  Cell culture for three-dimensional modeling in rotating-wall vessels: an application of simulated microgravity. , 1992, Journal of tissue culture methods : Tissue Culture Association manual of cell, tissue, and organ culture procedures.

[14]  Ali Khademhosseini,et al.  Bioprinting the Cancer Microenvironment. , 2016, ACS biomaterials science & engineering.

[15]  Najeeb M. Halabi,et al.  Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche , 2015, Journal of Translational Medicine.

[16]  Douglas W DeSimone,et al.  The extracellular matrix in development and morphogenesis: a dynamic view. , 2010, Developmental biology.

[17]  P. Netti,et al.  Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer. , 2017, Acta biomaterialia.

[18]  Jean J. Zhao,et al.  Bioprinting for cancer research. , 2015, Trends in biotechnology.

[19]  C. Ries,et al.  Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab , 2009, Oncogene.

[20]  M. Cekanova,et al.  Animal models and therapeutic molecular targets of cancer: utility and limitations , 2014, Drug design, development and therapy.

[21]  A. Sahebkar,et al.  Molecular imaging and cancer gene therapy. , 2016, Cancer gene therapy.

[22]  G. Rice,et al.  Multicellular spheroids in ovarian cancer metastases: Biology and pathology. , 2009, Gynecologic oncology.

[23]  Uwe Marx,et al.  Skin and hair on-a-chip: in vitro skin models versus ex vivo tissue maintenance with dynamic perfusion. , 2013, Lab on a chip.

[24]  G. Devi,et al.  Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. , 2016, Pharmacology & therapeutics.

[25]  Anne-Marie Mes-Masson,et al.  Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC) , 2007, Molecular carcinogenesis.

[26]  Xavier Paoletti,et al.  Precision medicine: lessons learned from the SHIVA trial - Authors' reply. , 2015, The Lancet. Oncology.

[27]  Ye Fang,et al.  Three-Dimensional Cell Cultures in Drug Discovery and Development. , 2017, SLAS discovery : advancing life sciences R & D.

[28]  Shuichi Takayama,et al.  Micro-ring structures stabilize microdroplets to enable long term spheroid culture in 384 hanging drop array plates , 2011, Biomedical Microdevices.

[29]  Kristian Pietras,et al.  Hallmarks of cancer: interactions with the tumor stroma. , 2010, Experimental cell research.

[30]  Xia Lou,et al.  High-Throughput Cancer Cell Sphere Formation for Characterizing the Efficacy of Photo Dynamic Therapy in 3D Cell Cultures , 2015, Scientific Reports.

[31]  L. Coussens,et al.  Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.

[32]  Hwan-You Chang,et al.  Recent advances in three‐dimensional multicellular spheroid culture for biomedical research , 2008, Biotechnology journal.

[33]  Peter C. Searson,et al.  In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform , 2016, Front. Bioeng. Biotechnol..

[34]  W. Sly,et al.  Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy , 2012, Clinical Cancer Research.

[35]  Curt Balch,et al.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.

[36]  Jia Xie,et al.  Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids , 2014, Journal of Ovarian Research.

[37]  V. V. Padma,et al.  An overview of targeted cancer therapy , 2015, BioMedicine.

[38]  D. Lauffenburger,et al.  Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.

[39]  S. Rafii,et al.  Akt-Activated Endothelium Constitutes the Niche for Residual Disease and Resistance to Bevacizumab in Ovarian Cancer , 2014, Molecular Cancer Therapeutics.

[40]  R. Kreitman Immunotoxins for targeted cancer therapy. , 1998, The AAPS journal.

[41]  L. Windus,et al.  Chemokine receptor expression on integrin-mediated stellate projections of prostate cancer cells in 3D culture. , 2013, Cytokine.

[42]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[43]  Jin Han,et al.  The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. , 2012, Biomaterials.

[44]  JONG BIN Kim,et al.  Three-dimensional tissue culture models in cancer biology. , 2005, Seminars in cancer biology.

[45]  Keekyoung Kim,et al.  3D bioprinting for engineering complex tissues. , 2016, Biotechnology advances.

[46]  J. McGee,et al.  TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. , 2016, Endocrine-related cancer.

[47]  Y. Chang,et al.  Contact inhibition, polyribosomes, and cell surface membranes in cultured mammalian cells , 1974, Journal of cellular physiology.

[48]  Chien-Chung Peng,et al.  Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic device , 2016, Scientific Reports.

[49]  A. Sood,et al.  Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP) , 2018, Oncogene.

[50]  H. Kurosawa Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. , 2007, Journal of bioscience and bioengineering.

[51]  N. Kotov,et al.  Three-dimensional cell culture matrices: state of the art. , 2008, Tissue engineering. Part B, Reviews.

[52]  S. Rafii,et al.  Endothelial Cells Provide a Notch-Dependent Pro-Tumoral Niche for Enhancing Breast Cancer Survival, Stemness and Pro-Metastatic Properties , 2014, PloS one.

[53]  Teck Chuan Lim,et al.  A microfluidic 3D hepatocyte chip for drug toxicity testing. , 2009, Lab on a chip.

[54]  M. Soleimani,et al.  Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening. , 2016, Tissue engineering. Part C, Methods.

[55]  L. Seymour,et al.  Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  Chengzhong Yu,et al.  Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. , 2013, Nanoscale.

[57]  S. Scaglione,et al.  Microenvironment complexity and matrix stiffness regulate breast cancer cell activity in a 3D in vitro model , 2016, Scientific Reports.

[58]  Joseph M. Negri,et al.  The role of tumour–stromal interactions in modifying drug response: challenges and opportunities , 2013, Nature Reviews Drug Discovery.

[59]  D. Radisky,et al.  Change in cell shape is required for matrix metalloproteinase‐induced epithelial‐mesenchymal transition of mammary epithelial cells , 2008, Journal of cellular biochemistry.

[60]  M. Ghert,et al.  Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.

[61]  M. Abercrombie,et al.  Contact inhibition in tissue culture , 1970, In Vitro.

[62]  G. Favre,et al.  SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction , 2015, BMC Cancer.

[63]  J. Batson,et al.  Regulation of contact inhibition of locomotion by Eph–ephrin signalling , 2013, Journal of microscopy.

[64]  Donna J. Webb,et al.  New dimensions in cell migration , 2003, Nature Cell Biology.

[65]  Martin Fussenegger,et al.  Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. , 2003, Biotechnology and bioengineering.

[66]  R. Kamm,et al.  Microfluidics: A new tool for modeling cancer-immune interactions. , 2016, Trends in cancer.

[67]  Gaudenz Danuser,et al.  Mathematical modeling of eukaryotic cell migration: insights beyond experiments. , 2013, Annual review of cell and developmental biology.

[68]  Shuichi Takayama,et al.  Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. , 2009, Biomaterials.

[69]  John Calvin Reed Apoptosis-targeted therapies for cancer. , 2003, Cancer cell.

[70]  A. Rafii,et al.  Role of the Microenvironment in Ovarian Cancer Stem Cell Maintenance , 2012, BioMed research international.

[71]  Anne-Claude Gavin,et al.  The social network of a cell: recent advances in interactome mapping. , 2008, Biotechnology annual review.

[72]  A. Skubitz,et al.  Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. , 2004, Gynecologic oncology.

[73]  R. Kreitman,et al.  Immunotoxins for targeted cancer therapy , 2006, The AAPS Journal.

[74]  U. N. Joensen,et al.  Hanging drop cultures of human testis and testis cancer samples: a model used to investigate activin treatment effects in a preserved niche , 2014, British Journal of Cancer.

[75]  Mark W. Tibbitt,et al.  Hydrogels as extracellular matrix mimics for 3D cell culture. , 2009, Biotechnology and bioengineering.

[76]  S. Oesterreich,et al.  Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression. , 2016, Cancer research.

[77]  H. Klocker,et al.  Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture , 2016, International journal of molecular sciences.

[78]  A. Ivascu,et al.  Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis , 2006, Journal of biomolecular screening.

[79]  Xiaofeng Cui,et al.  Application of inkjet printing to tissue engineering , 2006, Biotechnology journal.

[80]  Shuichi Takayama,et al.  384 hanging drop arrays give excellent Z‐factors and allow versatile formation of co‐culture spheroids , 2012, Biotechnology and bioengineering.

[81]  Jia-xin Yang,et al.  Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome. , 2011, Experimental and molecular pathology.

[82]  R. Foty,et al.  Biophysical measurement of brain tumor cohesion , 2005, International journal of cancer.

[83]  John Greenman,et al.  A Microfluidic System for Testing the Responses of Head and Neck Squamous Cell Carcinoma Tissue Biopsies to Treatment with Chemotherapy Drugs , 2011, Annals of Biomedical Engineering.

[84]  Shuichi Takayama,et al.  Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays. , 2015, Gynecologic oncology.

[85]  Daniel C. Scotto,et al.  BRAF inhibitors: resistance and the promise of combination treatments for melanoma , 2017, Oncotarget.

[86]  M. Abercrombie,et al.  Contact inhibition and malignancy , 1979, Nature.

[87]  J P Stegemann,et al.  Strategies for directing the structure and function of three-dimensional collagen biomaterials across length scales. , 2014, Acta biomaterialia.

[88]  L. Tanoue Cancer Statistics, 2009 , 2010 .

[89]  M J Bissell,et al.  How does the extracellular matrix direct gene expression? , 1982, Journal of theoretical biology.

[90]  R. Roberts,et al.  Drug-Induced Oxidative Stress and Toxicity , 2012, Journal of toxicology.

[91]  S. Takayama,et al.  Formation and manipulation of cell spheroids using a density adjusted PEG/DEX aqueous two phase system , 2015, Scientific Reports.

[92]  E. Voest,et al.  Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. , 2007, The oncologist.

[93]  G. Dunn,et al.  Analysing collisions between fibroblasts and fibrosarcoma cells: fibrosarcoma cells show an active invasionary response. , 1986, Journal of cell science.

[94]  D. Tarin Clinical and Biological Implications of the Tumor Microenvironment , 2012, Cancer Microenvironment.

[95]  N. E. Thomford,et al.  The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer , 2017, International journal of molecular sciences.

[96]  A. Ghanate,et al.  Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells , 2009, Stem cells.

[97]  Ying Huang,et al.  Organ Bioprinting: Are We There Yet? , 2018, Advanced healthcare materials.

[98]  H. Watari,et al.  Apoptosis and Molecular Targeting Therapy in Cancer , 2014, BioMed research international.

[99]  Anthony Atala,et al.  3D bioprinting of tissues and organs , 2014, Nature Biotechnology.

[100]  R. Parish,et al.  Mechanisms of Tumour Cell Metastasis , 1987, Journal of Cell Science.

[101]  R. Raphael,et al.  Assembly of a three-dimensional multitype bronchiole coculture model using magnetic levitation. , 2013, Tissue engineering. Part C, Methods.

[102]  Arjan W. Griffioen,et al.  Tumour vascularization: sprouting angiogenesis and beyond , 2007, Cancer and Metastasis Reviews.

[103]  F. Guillemot,et al.  High-throughput laser printing of cells and biomaterials for tissue engineering. , 2010, Acta biomaterialia.

[104]  M. Nündel,et al.  THE KINETICS OF CONTACT INHIBITION IN MAMMALIAN CELLS , 1977, Cell and tissue kinetics.

[105]  Anthony Atala,et al.  Printing Technologies for Medical Applications. , 2016, Trends in molecular medicine.

[106]  Noo Li Jeon,et al.  Biomimetic Model of Tumor Microenvironment on Microfluidic Platform , 2017, Advanced healthcare materials.

[107]  N. Cho,et al.  CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells , 2010, Oncogene.

[108]  A. Ludwig,et al.  Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases , 2017, Mediators of Inflammation.

[109]  R. Doebele,et al.  A framework for understanding and targeting residual disease in oncogene-driven solid cancers , 2016, Nature Medicine.

[110]  Kenneth M. Yamada,et al.  Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.

[111]  Shuichi Takayama,et al.  High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. , 2011, The Analyst.

[112]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[113]  Zhixiong Zhang,et al.  Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells. , 2016, Lab on a chip.

[114]  R. Sutherland,et al.  Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. , 1971, Journal of the National Cancer Institute.

[115]  J. Kelm,et al.  Evaluation of assays for drug efficacy in a three-dimensional model of the lung , 2016, Journal of Cancer Research and Clinical Oncology.

[116]  P. Kovacic,et al.  Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. , 2000, Current pharmaceutical design.

[117]  Kwangmeyung Kim,et al.  Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. , 2011, Biomaterials.

[118]  M. Lebourg,et al.  Three-dimensional constructs using hyaluronan cell carrier as a tool for the study of cancer stem cells. , 2015, Journal of biomedical materials research. Part B, Applied biomaterials.

[119]  G. Whitesides The origins and the future of microfluidics , 2006, Nature.

[120]  Mina J. Bissell,et al.  Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices , 2009, Cancer and Metastasis Reviews.

[121]  D. Kaplan,et al.  A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function. , 2010, Biomaterials.

[122]  Mikaël M. Martino,et al.  Extracellular Matrix and Growth Factor Engineering for Controlled Angiogenesis in Regenerative Medicine , 2015, Front. Bioeng. Biotechnol..

[123]  G. Dubini,et al.  A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. , 2014, Biomaterials.

[124]  L. Griffith,et al.  A microfabricated array bioreactor for perfused 3D liver culture. , 2002, Biotechnology and bioengineering.

[125]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[126]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[127]  R. Agarwal,et al.  Mechanisms of transcoelomic metastasis in ovarian cancer. , 2006, The Lancet. Oncology.

[128]  Ying Huang,et al.  3D bioprinting and the current applications in tissue engineering , 2017, Biotechnology journal.

[129]  James A Bankson,et al.  Three-dimensional tissue culture based on magnetic cell levitation. , 2010, Nature nanotechnology.

[130]  J. Yuhas,et al.  A simplified method for production and growth of multicellular tumor spheroids. , 1977, Cancer research.

[131]  J. Marks,et al.  Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells , 2009, Oncogene.

[132]  Bjoern Rodday,et al.  Test System for Trifunctional Antibodies in 3D MCTS Culture , 2009, Journal of biomolecular screening.

[133]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[134]  Donald E Ingber,et al.  Microengineered physiological biomimicry: organs-on-chips. , 2012, Lab on a chip.

[135]  Sierin Lim,et al.  Bioengineered three‐dimensional co‐culture of cancer cells and endothelial cells: A model system for dual analysis of tumor growth and angiogenesis , 2017, Biotechnology and bioengineering.

[136]  M. Abercrombie,et al.  Observations on the social behaviour of cells in tissue culture. I. Speed of movement of chick heart fibroblasts in relation to their mutual contacts. , 1953, Experimental cell research.

[137]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[138]  J. Burdick,et al.  A practical guide to hydrogels for cell culture , 2016, Nature Methods.

[139]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[140]  Tiffany W Guo,et al.  Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. , 2008, Molecular biology of the cell.

[141]  Dietmar W. Hutmacher,et al.  Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. , 2010, Biomaterials.

[142]  R. Sutherland,et al.  A multi-component radiation survival curve using an in vitro tumour model. , 1970, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[143]  P. Oliveira,et al.  The contribution of oxidative stress to drug-induced organ toxicity and its detection in vitro and in vivo , 2012, Expert opinion on drug metabolism & toxicology.

[144]  Forrest M Kievit,et al.  Culture on 3D Chitosan‐Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells , 2016, Advanced healthcare materials.

[145]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[146]  Biana Godin,et al.  Three-Dimensional In Vitro Co-Culture Model of Breast Tumor using Magnetic Levitation , 2014, Scientific Reports.

[147]  Shereen R Kadir,et al.  Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells , 2010, Nature Cell Biology.

[148]  Mikaël M. Martino,et al.  Engineering the Regenerative Microenvironment with Biomaterials , 2013, Advanced healthcare materials.

[149]  Catarina Brito,et al.  Adaptable stirred-tank culture strategies for large scale production of multicellular spheroid-based tumor cell models. , 2016, Journal of biotechnology.

[150]  R. Mattingly,et al.  Three-Dimensional Overlay Culture Models of Human Breast Cancer Reveal a Critical Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibitors , 2010, Journal of Pharmacology and Experimental Therapeutics.

[151]  C. Ries,et al.  Fibroblasts Influence Survival and Therapeutic Response in a 3D Co-Culture Model , 2015, PloS one.

[152]  M. Abercrombie,et al.  Social behaviour of cells in tissue culture. III. Mutual influence of sarcoma cells and fibroblasts. , 1957, Experimental cell research.

[153]  Jason A Burdick,et al.  Recent advances in hyaluronic acid hydrogels for biomedical applications. , 2016, Current opinion in biotechnology.

[154]  Qian Peng,et al.  An outline of the hundred-year history of PDT. , 2003, Anticancer research.

[155]  Levi A Garraway,et al.  Circumventing cancer drug resistance in the era of personalized medicine. , 2012, Cancer discovery.

[156]  Y. Luqmani Mechanisms of Drug Resistance in Cancer Chemotherapy , 2005, Medical Principles and Practice.

[157]  I. Pastan,et al.  Advances in anticancer immunotoxin therapy. , 2015, The oncologist.

[158]  H. Kimura,et al.  An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models. , 2008, Lab on a chip.